AzTrials
AzTrials

Psychosocial ProblemNCT04234815

Evaluating Impacts of CSS for Veterans and Their Families in Ukraine

A study testing CETA Short Session (CSS) and Psychoeducation and Safety in people with Psychosocial Problem and Psychological Distress, run by Johns Hopkins Bloomberg School of Public Health at 1 site in Ukraine.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This cluster-randomized controlled trial (c-RCT) evaluates the effectiveness of a brief, single-session psychosocial workshop, "CETA Short Session" (CSS), for reducing symptoms of distress and functional impairment and increasing treatment engagement among conflict veterans and their families in Ukraine. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
CETA Short Session (CSS) and Psychoeducation and Safety
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,193 participants
Where
1 siteUkraine
Study dates
28 Feb 2020to 23 Feb 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Ukrainian adults (age 18 or older) who are Veterans of the Anti-Terrorist Operations (ATO) in Ukraine or an adult family member of a veteran
  • Meets a minimum total problem score on the locally validated screener indicative of at least moderate symptoms of distress

Who cannot join

  • People who identify as ATO veterans but are still active (i.e., active duty) in the Ukrainian military.
  • Participants who arrive late to the workshop, operationalized as not having time to participate in the self-assessment review, will be excluded. In online workshops, late-arriving participants will be redirected to a waiting room, where they will be encouraged to attend a future session instead (and if so, could be included in the study). For in-person workshops, due to travel and other efforts required for attendance late arriving participants will be allowed to join the workshop, but excluded from the study due to lacking sufficient exposure. They can also choose to attend a future workshop, but if attending a portion of an initial workshop would remain study ineligible because they could potentially be exposed to both arms of the study.
  • Participants who are identified by service providers as needing higher-level care rather than outpatient psychotherapy will be immediately referred to that care and excluded from the study. This exclusion criteria refers to imminent danger to self or others that requires urgent safety procedures and institution-based mental health care.

Trial locations and contacts

1 site in 1 country.

Ukraine1 site
  • NaUKMA

    Kyiv

Other trials in Ukraine

About this study

Official title: Evaluating Impacts of a Brief Psychosocial Workshop for Veterans and Their Families in Ukraine

This cluster-randomized controlled trial (c-RCT) evaluates the effectiveness of a brief, single-session psychosocial workshop, "CETA Short Session" (CSS), for reducing symptoms of distress and functional impairment and increasing treatment engagement among conflict veterans and their families in Ukraine. The CSS workshop includes psychoeducation, review of a self-assessment, safety screening, and training in cognitive coping. This will be evaluated against a single-session comparison workshop that includes all of the same workshop elements except for cognitive coping. Registration for both conditions includes completion of a self-assessment. Participants with safety concerns or very severe symptoms will be immediately referred to mental health treatment; others will be asked to wait for one month before being reassessed and, if indicated, referred to mental health treatment. Both conditions include an individual check-in phone call one week after the workshop. Distress and functional impairment outcomes will be assessed one month from baseline. Treatment engagement outcomes will be assessed three months from referral. The investigators hypothesize that individuals attending sessions randomized to CSS will show greater improvement in mental health outcomes and greater treatment engagement than those attending sessions randomized to the comparison condition.

With the onset of the COVID-19 pandemic in Spring 2019, the RCT was paused to develop and pilot an online version of both the CSS and comparison workshop. The trial protocol has now been expanded to continue the effectiveness trial while allowing for both online and [when/if feasible] in-person intervention delivery.

Read the detailed description

Community-based organizations in Ukraine that are currently providing social services to veterans or their families and are interested in receiving training to provide CSS will be engaged as implementing partners. Individuals selected to be providers at these organizations will complete a 2-day Provider Training and will additionally receive ongoing supervision over the course of the study to ensure intervention fidelity and appropriate response and support to individuals needing referral to mental health treatment.

Cluster-level randomization to CSS or eTAU will be carried out at the workshop level within provider, such that all Providers will deliver both the CSS and eTAU workshops to groups that have been randomly allocated to either receive CSS or eTAU. In this way, all organizations will offer both CSS and eTAU, integrated into each organization's regular program offerings and advertised through organizations' regular communication channels.

As part of the registration and triage procedures included as regular programming in both arms of the trial, participants will self-complete a short, locally validated Self-Assessment Form that assesses symptoms of distress (depression, post-traumatic stress), functional impairment, and safety risk (two safety-related questions assessing recent thoughts of harm to self or others). This assessment will be completed in advance and reviewed by an M\&E staff member prior to the workshop, but assessment scores will not determine workshop eligibility (e.g., people with low scores can still participate). One exception to this is that any individuals who respond positively to either of the safety questions will be contacted by the CSS/eTAU provider within 24-hours for further safety assessment. If no safety issues are identified, they will be registered for the workshop as normal; however, identified safety issues will trigger an appropriate safety planning or referral response as described below, which may include bypassing the workshop in lieu of direct enrollment in treatment services. At the end of the workshop, participants will be informed of the study and invited to participate; those who agree will provide informed consent.

After the workshop, as part of regular programming the provider will follow up individually with participants to discuss recommended next steps. Evaluation of level of need, and therefore choice of follow-up response, will be made by the provider using the self-assessment results as well as any information reported to the provider during the workshop (such as new safety concerns, or changes in problem scores). Follow-up contacts will be ordered by priority.

  1. Individuals who indicate any new safety concerns at the workshop will be contacted within 24 hours for further assessment to determine the appropriate referrals and/or safety plan.
  2. Individuals with high symptom scores, but no safety concerns, will be contacted within 72 hours and offered a referral to outpatient mental health care.
  3. Individuals with moderate symptom scores will be contacted within 1 week for triage and encouraged to use the newly learned skills over the next month. On that triage phone call, participants will be told they will be re-assessed in one month to determine if they still require mental health treatment (at which time they would be referred if indicated). For those who attended CSS (rather than eTAU), providers will also ask about participant use of the cognitive coping skill over the past week, including asking them how often they've used it, whether it has been helpful, and soliciting an example through a series of questions that walk them through the skill.

At one month, all study participants who were not immediately referred to outpatient mental health services at baseline will be sent an individual link to re-administer the self-assessment, the CSS skill check, and complete an implementation feedback questionnaire.

For all study participants who receive an outpatient mental health referral, either immediate or delayed, engagement outcomes will be assessed three months following referral.

Being tested
CETA Short Session (CSS), Psychoeducation and Safety
Keywords
Mental health, Psychosocial support, Intervention, Depression, Post-traumatic stress, Functioning
Medical subject headings
Patient Participation, Psychological Well-Being, Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CETA Short Session (CSS)Behavioural

    CETA Short Session (CSS) is a brief, low-intensity psychosocial intervention incorporating foundational components of the Common Elements Treatment Approach (CETA). CETA is an 8-12 session, transdiagnostic psychotherapy for common mental disorders. CSS was designed to serve as both a prevention/support approach for a broader range of needs, as well as an engagement/outreach strategy to identify and refer individuals to treatment. CSS is delivered in a group format over approximately two hours and consists of: 1) Psychoeducation: instruction about the brain and brain functioning, including normalization of psychological responses to stress and a brief self-assessment; 2) Safety: screening and referral for individuals identified as at risk of harm to self or others; and 3) Cognitive coping: based on the cognitive triangle, participants practice identifying an unhelpful thought changing it to a more helpful alternative, and examining how these thoughts impact feelings and behaviors.

  • Psychoeducation and SafetyBehavioural

    This intervention is the same as CSS with the exception that the cognitive coping skill training is removed.

Study groups in NCT04234815
Study groupRoleWhat they receive
CETA Short Session (CSS)ExperimentalA single-session, 1.5-2 hour group workshop that includes psychoeducation, self-assessment, safety screening, and training in cognitive coping. Participants with at least moderate symptoms of distress will also receive a follow-up phone call to discuss next steps occurring within one week after workshop attendance. On this phone call they will also be asked about their use of the cognitive coping skill over the last week, and provided feedback if using it incorrectly.
Receives: Behavioral: CETA Short Session (CSS)
Enhanced Treatment as Usual (eTAU)Active comparatorA single-session, approximately 1-hour group workshop that includes the same psychoeducation, self-assessment, and safety screening as the experimental condition, but no training in cognitive coping. Participants with at least moderate symptoms of distress will also receive a follow-up phone call to discuss next steps occurring within one week after workshop attendance.
Receives: Behavioral: Psychoeducation and Safety

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in mental health symptom scores

    International Depression Symptom Scale (IDSS): a locally-validated self-report instrument that produces total and syndrome-specific scores. (range: 0-54, higher indicates more symptomatic)

    Measured: Baseline, 1-month follow-up

  2. Mental health treatment engagement

    Follow-up on referral to mental health treatment, derived from client monitoring records (indicated as yes/no)

    Measured: 3 months following referral to mental health treatment

  3. Change in functional impairment

    a locally developed (based on qualitative data) and validated self-report instrument that produces a functional impairment score (range: 0-56, higher scores indicate greater functional impairment)

    Measured: Baseline, 1-month follow-up

Secondary outcomes (3)
  1. Aggression

    Items adapted (based on qualitative data) from the Conflict Tactics Scale - Revised (range: 0-18, higher scores indicate more aggression)

    Measured: Baseline, 1-month follow-up

  2. Social Connectedness

    Items adapted (based on qualitative data) from the Social Connectedness Scale - Revised (range: 0-24, higher scores indicate greater disconnection)

    Measured: Baseline, 1-month follow-up

  3. Alcohol consumption

    AUDIT-C scores (range: 0-12, higher scores indicate greater substance use)

    Measured: Baseline, 1-month follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Jan 2020
  2. Study start28 Feb 2020
  3. Primary completion23 Feb 2022
  4. Study completion23 Feb 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
1,193 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04234815
Sponsor's protocol ID
9782
Status last verified
Sep 2022
First submitted
16 Jan 2020
Last updated
29 Sep 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing CETA Short Session (CSS) and Psychoeducation and Safety in people with Psychosocial Problem and Psychological Distress, run by Johns Hopkins Bloomberg School of Public Health at 1 site in Ukraine.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Sep 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Ukraine. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in mental health symptom scores (time frame: Baseline, 1-month follow-up). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Sep 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in